表紙
市場調查報告書
商品編碼
422560

肉毒桿菌、玻尿酸 (HA) 填充劑的全球市場:產業分析與未來展望

Global Botulinum Toxin & HA Dermal Filler Market: Industry Analysis & Outlook 2018-2022

出版日期: | 出版商: Koncept Analytics | 英文 107 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球肉毒桿菌 (BX) 及玻尿酸填充物 (填充劑)的市場相關分析,產品、治療方法概要,及全球整體的市場趨勢預測,各地區及各用途 (美容整形等)的詳細趨勢,主要的推動及阻礙市場要素,主要企業簡介、市場佔有率、業績等的相關調查。

第1章 簡介

  • 市場概要

第2章 美容整形市場

  • 全球市場
    • 美容整形的治療數量 (以金額為準)
    • 美容整形的治療數量 (以金額為準,預測值)
    • 美容整形的治療數量:各類別
    • 美容整形的治療數量:各類型

第3章 全球肉毒桿菌、玻尿酸填充劑的市場

  • 肉毒桿菌
    • 肉毒桿菌的市場規模 (以金額為準)
    • 肉毒桿菌的市場規模 (以金額為準,預測值)
    • 肉毒桿菌的市場規模:各地區
    • 肉毒桿菌的市場規模:各領域
    • 治療用肉毒桿菌的市場規模 (以金額為準)
    • 治療用肉毒桿菌的市場規模 (以金額為準,預測值)
    • 美容用肉毒桿菌的市場規模 (以金額為準)
    • 美容用肉毒桿菌的市場規模 (以金額為準,預測值)
    • 美容用肉毒桿菌的市場規模 (以數量為準)
    • 美容用肉毒桿菌的市場規模 (以數量為準,預測值)
  • 玻尿酸 (HA) 填充劑
    • 玻尿酸填充劑的市場規模 (以金額為準)
    • 玻尿酸填充劑的市場規模 (以金額為準,預測值)
    • 美容用玻尿酸填充劑的市場規模 (以數量為準)
    • 美容用玻尿酸填充劑的市場規模 (以數量為準,預測值)

第4章 各地區的肉毒桿菌、玻尿酸填充劑的市場

  • 美國
    • 肉毒桿菌的市場規模 (以金額為準)
    • 肉毒桿菌的市場規模 (以金額為準,預測值)
    • 治療用肉毒桿菌的市場規模 (以金額為準)
    • 治療用肉毒桿菌的市場規模 (以金額為準,預測值)
    • 美容用肉毒桿菌的市場規模 (以數量為準)
    • 美容用肉毒桿菌的市場規模 (以數量為準,預測值)
  • 歐洲
  • 其他的國家 (RoW)
    • RoW市場全體
    • 韓國市場 (玻尿酸填充劑/肉毒桿菌的市場規模)
    • 中國市場 (玻尿酸填充劑的市場規模)

第5章 市場動態

  • 成長推動因素
  • 主要趨勢和動靜
  • 課題

第6章 市場競爭

  • 全球市場
    • 全球肉毒桿菌市場:各企業市場佔有率
    • 全球玻尿酸填充劑市場:各企業市場佔有率
  • 地區市場
    • 中國的肉毒桿菌市場:各企業市場佔有率
    • 中國的玻尿酸填充劑市場:各企業市場佔有率
    • 韓國的肉毒桿菌市場:各企業市場佔有率
    • 韓國的玻尿酸填充劑市場:各企業市場佔有率

第7章 企業簡介

目錄

Botulinum Toxin (Botox or BTX) is a poisonous natural protein, created by the bacteria named Clostridium Botulinum. Generally, botulinum toxin is used by the surgeons to obstruct the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction. According to the exotoxins, botulinum toxin can be classified into eight product types including botulinum toxin A, B, C1, D, E, F, G and H.

Hyaluronic Acid (HA) is a naturally occurring non-sulfated glycosaminoglycan polymer component of the extracellular matrix that consists of repeat disaccharide units of glucuronic acid and N-acetyl-glucosamine. HA dermal fillers are widely used to replace and restore human tissue and are commonly used in medical aesthetic surgeries. However, unlike botulinum toxin which is directly used to restrict a particular muscle movement, HA dermal fillers are directly injected into the skin to fill wrinkles /dermal or folded points on the body part.

The U.S. emerged as a major region for the botulinum toxin and HA dermal fillers market, due to increased demand for minimally invasive or non-invasive facial cosmetic procedures by the residents of the U.S. supported by growth in their respective disposable income and increased tertiary health care concerns with the development of ageing symptoms.

The global botulinum toxin and HA dermal filler market is expected to grow with emerging middle class population, rising female populace in the workforce, increasing pharmaceutical R&D spending, growing health care expenditure and accelerating economic growth. Key trends of this market includes increasing plastic surgeon population, rising demand for minimally invasive procedures in the U.S. and growing preference for combination therapy. However, there are some factors which can hinder growth of the market including stringent regulations, patient health-associated risks, dominance of botulinum toxin and HA Dermal Filler alternatives and limited access to patent rights.

The report "Global Botulinum Toxin and HA Dermal Filler Market: Industry Analysis & Outlook (2018-2022)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the U.S., Europe, Japan, Korea, China along with the global market. The report profiles the key players of the market including Allergan Plc, Ipsen S.A., Shanghai Haohai Biological Technology Co. Ltd and Medytox Inc.

Table of Contents

1. Market Overview

  • 1.1 Aesthetics
  • 1.2 Botulinum Toxin
  • 1.3 HA Dermal Filler

2. Global Aesthetic Market

  • 2.1 Medical Aesthetic Procedures
  • 2.2 Medical Aesthetic Procedures Forecast
  • 2.3 Medical Aesthetic Procedures by Category
  • 2.4 Medical Aesthetic Procedures by Product Types

3. Global Botulinum Toxin and HA Dermal Filler Market

  • 3.1 Botulinum Toxin Market
    • 3.1.1 Global Botulinum Toxin Market by Value
    • 3.1.2 Global Botulinum Toxin Market Forecast by Value
    • 3.1.3 Global Botulinum Toxin Market Value by Region
    • 3.1.4 Global Botulinum Toxin Market Value by Application
    • 3.1.5 Global Botulinum Toxin Therapeutics Market by Value
    • 3.1.6 Global Botulinum Toxin Therapeutics Market Forecast by Value
    • 3.1.7 Global Botulinum Toxin Medical Aesthetics Market by Value
    • 3.1.8 Global Botulinum Toxin Medical Aesthetics Market Forecast by Value
    • 3.1.9 Global Botulinum Toxin Medical Aesthetics Procedures
    • 3.1.10 Global Botulinum Toxin Medical Aesthetics Procedures Forecast
    • 3.1.11 Global Botulinum Toxin Medical Aesthetics Procedures by Region
  • 3.2 HA Dermal Filler Market
    • 3.2.1 Global HA Dermal Filler Market by Value
    • 3.2.2 Global HA Dermal Filler Market Forecast by Value
    • 3.2.3 Global HA Dermal Filler Procedures
    • 3.2.4 Global HA Dermal Filler Procedures Forecast
    • 3.2.5 Global HA Dermal Filler Procedures by Region

4. Regional Botulinum Toxin and HA Dermal Filler Market

  • 4.1 The U.S.
    • 4.1.1 The U.S. Botulinum Toxin Market by Value
    • 4.1.2 The U.S. Botulinum Toxin Market Forecast by Value
    • 4.1.3 The U.S. Botulinum Toxin Market Value by Application
    • 4.1.4 The U.S. Botulinum Toxin Therapeutics Market by Value
    • 4.1.5 The U.S. Botulinum Toxin Therapeutics Market Forecast by Value
    • 4.1.6 The U.S. Botulinum Toxin Medical Aesthetics Market by Value
    • 4.1.7 The U.S. Botulinum Toxin Medical Aesthetics Market Forecast by Value
    • 4.1.8 The U.S. Botulinum Toxin Medical Aesthetics Procedures Forecast
    • 4.1.9 The U.S. HA Dermal Filler Procedures Forecast
  • 4.2 Europe
    • 4.2.1 Europe Botulinum Toxin Market by Value
    • 4.2.2 Europe Botulinum Toxin Market Forecast by Value
    • 4.2.3 Europe Botulinum Toxin Market Value by Application
    • 4.2.4 Europe Botulinum Toxin Therapeutics Market by Value
    • 4.2.5 Europe Botulinum Toxin Therapeutics Market Forecast by Value
    • 4.2.6 Europe Botulinum Toxin Medical Aesthetics Market by Value
    • 4.2.7 Europe Botulinum Toxin Medical Aesthetic Market Forecast by Value
  • 4.3 Japan
    • 4.3.1 Japan Botulinum Toxin Market by Value
    • 4.3.2 Japan Botulinum Toxin Market Forecast by Value
  • 4.4 Korea
    • 4.4.1 Korea Botulinum Toxin Market by Value
    • 4.4.2 Korea Botulinum Toxin Market Forecast by Value
    • 4.4.3 Korea Botulinum Toxin Medical Aesthetic Procedures Forecast
    • 4.4.4 Korea HA Dermal Filler Market by Value
    • 4.4.5 Korea HA Dermal Filler Market Forecast by Value
  • 4.5 China
    • 4.5.1 China HA Dermal Filler Market by Value
    • 4.5.2 China HA Dermal Filler Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Emerging Middle Class Population
    • 5.1.2 Rising Females in the Workforce
    • 5.1.3 Increasing Pharmaceutical R&D Spending
    • 5.1.4 Growing Health Care Expenditure
    • 5.1.5 Accelerating Economic Growth
  • 5.2 Key Trends and Developments
    • 5.2.1 Increasing Plastic Surgeon Population
    • 5.2.2 Rising Demand for Minimally Invasive Procedures in the U.S.
    • 5.2.3 Growing Preference for Combination Therapy
  • 5.3 Challenges
    • 5.3.1 Stringent Regulations
    • 5.3.2 Patient Health-Associated Risk
    • 5.3.3 Dominance of Botulinum Toxin and HA Dermal Filler Alternatives
    • 5.3.4 Limited Access to Patent Rights

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Global Botulinum Toxin Major Brands by Company
    • 6.1.3 Botulinum Toxin Market Share by Company
    • 6.1.4 Global HA Dermal Filler Market Share by Company
  • 6.2 Regional Market
    • 6.2.1 Korea Botulinum Toxin Market Share by Company
    • 6.2.2 Korea HA Dermal Filler Market Share by Company
    • 6.2.3 China Botulinum Toxin Market Share by Company
    • 6.2.4 China HA Dermal Filler Market Share by Company

7. Company Profiles

  • 7.1 Allergan Plc
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Ipsen S.A.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Shanghai Haohai Biological Technology Co. Ltd
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Medytox Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Figures

  • Medical Aesthetics Procedure Categories
  • Medical Aesthetic Procedure Product Types
  • Application of Botulinum Toxin
  • Global Medical Aesthetic Procedures (2013-2017)
  • Global Medical Aesthetic Procedures Forecast (2018-2022)
  • Global Medical Aesthetic Procedures by Category (2017)
  • Global Medical Aesthetic Procedures by Product Types (2017)
  • Global Botulinum Toxin Market by Value (2013-2017)
  • Global Botulinum Toxin Market Forecast by Value (2018-2022)
  • Global Botulinum Toxin Market Value by Region (2017)
  • Global Botulinum Toxin Market Value by Application (2017)
  • Global Botulinum Toxin Therapeutics Market by Value (2013-2017)
  • Global Botulinum Toxin Therapeutics Market Forecast by Value (2018-2022)
  • Global Botulinum Toxin Medical Aesthetics Market by Value (2013-2017)
  • Global Botulinum Toxin Medical Aesthetics Market Forecast by Value (2018-2022)
  • Global Botulinum Toxin Medical Aesthetics Procedures (2013-2017)
  • Global Botulinum Toxin Medical Aesthetics Procedures Forecast (2018-2022)
  • Global Botulinum Toxin Medical Aesthetics Procedures by Region (2017)
  • Global HA Dermal Filler Market by Value (2013-2017)
  • Global HA Dermal Filler Market Forecast by Value (2018-2022)
  • Global HA Dermal Filler Procedures (2013-2017)
  • Global HA Dermal Filler Procedures Forecast (2018-2022)
  • Global HA Dermal Filler Procedures by Region (2017)
  • The U.S. Botulinum Toxin Market by Value (2013-2017)
  • The U.S. Botulinum Toxin Market Forecast by Value (2018-2022)
  • The U.S. Botulinum Toxin Market Value by Application (2017)
  • The U.S. Botulinum Toxin Therapeutics Market by Value (2013-2017)
  • The U.S. Botulinum Toxin Therapeutics Market Forecast by Value (2018-2022)
  • The U.S. Botulinum Toxin Medical Aesthetics Market by Value (2013-2017)
  • The U.S. Botulinum Toxin Medical Aesthetics Market Forecast by Value (2018-2022)
  • The U.S. Botulinum Toxin Medical Aesthetics Procedures Forecast (2017-2022)
  • The U.S. HA Dermal Filler Procedures Forecast (2017-2022)
  • Europe Botulinum Toxin Market by Value (2013-2017)
  • Europe Botulinum Toxin Market Forecast by Value (2018-2022)
  • Europe Botulinum Toxin Market Value by Application (2017)
  • Europe Botulinum Toxin Therapeutics Market by Value (2013-2017)
  • Europe Botulinum Toxin Therapeutics Market Forecast by Value (2018-2022)
  • Europe Botulinum Toxin Medical Aesthetics Market by Value (2013-2017)
  • Europe Botulinum Toxin Medical Aesthetic Market Forecast by Value (2018-2022)
  • Japan Botulinum Toxin Market by Value (2013-2017)
  • Japan Botulinum Toxin Market Forecast by Value (2018-2022)
  • Korea Botulinum Toxin Market by Value (2013-2017)
  • Korea Botulinum Toxin Market Forecast by Value (2018-2022)
  • Korea Botulinum Toxin Medical Aesthetic Procedures Forecast (2017-2022)
  • Korea HA Dermal Filler Market by Value (2013-2017)
  • Korea HA Dermal Filler Market Forecast by Value (2018-2022)
  • China HA Dermal Filler Market by Value (2013-2017)
  • China HA Dermal Filler Market Forecast by Value (2018-2022)
  • Global Middle Class Population (2015-2028)
  • Global Working Women Population (2013-2017)
  • Global Pharmaceutical R&D Spending (2013-2017)
  • Global Health Care Expenditure (2013-2017)
  • Global GDP Per Capita (2013-2017)
  • Global Plastic Surgeon Population (2013-2017)
  • The U.S. Aesthetic Procedures (2013-2017)
  • Global Botulinum Toxin Major Brands by Company (2017)
  • Global Botulinum Toxin Market Share by Company (2017)
  • Global HA Dermal Filler Market Share by Company (2017)
  • Korea Botulinum Toxin Market Share by Company (2017)
  • Korea HA Dermal Filler Market Share by Company (2017)
  • China Botulinum Toxin Market Share by Company (2017)
  • China HA Dermal Filler Market Share by Company (2017)
  • Allergan Plc Net Revenues by Business Segments (2017)
  • Allergan Plc Net Revenues and Net Income (Loss) (2013-2017)
  • Allergan Plc Research and Development Expenditures (2015-2017)
  • Ipsen S.A. Net Sales by Business Segments (2017)
  • Ipsen S.A. Net Sales and Net Profit (2013-2017)
  • Ipsen S.A. Research and Development Expenditures (2015-2017)
  • Shanghai Haohai Biological Technology Revenues by Business Segments (2017)
  • Shanghai Haohai Biological Technology Revenues and Net Profit (2014-2017)
  • Shanghai Haohai Biological Technology R&D Expenditures (2015-2017)
  • Medytox Inc. Product Pipeline (2018)
  • Medytox Inc. Revenues and Net Profit (2014-2017)

List of Tables

  • Botulinum Toxin-A Major Product Description
  • Key Players - Revenues Comparison (2017)
  • Ipsen S.A. Significant Agreements (2017/2018)